Literature DB >> 15629147

A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis.

Martin L Katz1, Shahnawaz Khan, Tomoyuki Awano, S Adam Shahid, Aristotle N Siakotos, Gary S Johnson.   

Abstract

A heritable neurodegenerative disease of English Setters has long been studied as a model of human neuronal ceroid-lipofuscinosis (NCL). Megablast searches of the first build of the canine genome for potential causative genes located the CLN8 gene near the q telomere of canine chromosome 37, close to a marker previously linked to English Setter NCL. Sequence analysis of the coding region from affected dogs revealed a T-to-C transition in the CLN8 gene that predicts a p.L164P missense mutation. Leucine 164 is conserved in four other mammalian species. The C allele co-segregated with the disease phenotype in a two-generation English Setter family in a pattern consistent with autosomal recessive inheritance. All four NCL-affected family members were C/C homozygotes and all four obligate carriers were C/T heterozygotes; whereas, 103 unrelated dogs were all T/T homozygotes. These findings indicate that the CLN8 T-to-C transition is the likely cause of English Setter NCL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629147     DOI: 10.1016/j.bbrc.2004.12.038

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

1.  [NCL in animal models].

Authors:  K Rüther
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

Review 2.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

Review 3.  Man's best friend becomes biology's best in show: genome analyses in the domestic dog.

Authors:  Heidi G Parker; Abigail L Shearin; Elaine A Ostrander
Journal:  Annu Rev Genet       Date:  2010       Impact factor: 16.830

4.  Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).

Authors:  Graham W Kay; Marcel M Verbeek; Julie M Furlong; Michèl A A P Willemsen; David N Palmer
Journal:  Neurochem Int       Date:  2009-08-05       Impact factor: 3.921

Review 5.  Large animal models for Batten disease: a review.

Authors:  Krystal Weber; David A Pearce
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

6.  A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.

Authors:  Natalie A Villani; Garrett Bullock; Jennifer R Michaels; Osamu Yamato; Dennis P O'Brien; Tendai Mhlanga-Mutangadura; Gary S Johnson; Martin L Katz
Journal:  Mol Genet Metab       Date:  2019-04-17       Impact factor: 4.797

Review 7.  Canine epilepsy genetics.

Authors:  Kari J Ekenstedt; Edward E Patterson; James R Mickelson
Journal:  Mamm Genome       Date:  2011-10-30       Impact factor: 2.957

Review 8.  Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions.

Authors:  Martin L Katz; Eline Rustad; Grace O Robinson; Rebecca E H Whiting; Jeffrey T Student; Joan R Coates; Kristina Narfstrom
Journal:  Neurobiol Dis       Date:  2017-08-30       Impact factor: 5.996

9.  Genome-wide linkage scan for loci associated with epilepsy in Belgian shepherd dogs.

Authors:  Anita M Oberbauer; Janelle M Belanger; Deborah I Grossman; Kelly R Regan; Thomas R Famula
Journal:  BMC Genet       Date:  2010-05-04       Impact factor: 2.797

10.  A neonatal encephalopathy with seizures in standard poodle dogs with a missense mutation in the canine ortholog of ATF2.

Authors:  Xuhua Chen; Gary S Johnson; Robert D Schnabel; Jeremy F Taylor; Gayle C Johnson; Heidi G Parker; Edward E Patterson; Martin L Katz; Tomoyuki Awano; Shahwanaz Khan; Dennis P O'Brien
Journal:  Neurogenetics       Date:  2007-12-12       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.